09.12.2014 • NewsSigma-AldrichMercktransaction

Sigma-Aldrich Shareholders Approve Takeover by Merck

At a special meeting held at the Sigma-Aldrich Life Science and Technology Center in St. Louis, Missouri, USA, 78% of the company's shareholders approved the planned takeover by Germany's Merck KGaA for $17 billion in cash. The Sigma-Aldrich board of directors had previously unanimously approved the deal.

Under the agreement announced on Sept. 22, 2014, Merck will acquire all of the outstanding Sigma-Aldrich shares for $140 per share in cash. A Merck shareholder vote is not required.

The Darmstadt-based chemical and pharmaceutical producer said it continues to expect to close the transaction, which is still subject to regulatory approvals, in mid- 2015. It said it is "is working closely with authorities to ensure a seamless transaction."

Merck said the acquisition is a key element in its "Fit for 2018" transformation and growth program aimed at strengthening its healthcare, life science and performance materials platforms.

The merger of Sigma-Aldrich and Merck's laboratory chemicals offshoot Merck Millipore would be able to offer the Laboratory & Academia sector a complementary range of products across laboratory chemicals, biologics and reagents.

In pharma and biopharma production, Merck said Sigma-Aldrich would complement Merck Millipore's existing products and capabilities with additions along the entire value chain of drug production and validation.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.